Bayer Animal Health announces that Baytril 100 (enrofloxacin) Injectable has been approved by the Food and Drug Administration for treatment of Mycoplasma bovis — a major pathogen for Bovine Respiratory Disease (BRD) that has a significant health and economic impact on cattle operations across the country.

With this approval, Baytril 100 (enrofloxacin) is now labeled and proven effective as a single-injection treatment for all major pathogens of BRD in cattle and non-lactating dairy heifers less than 20 months of age, including Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis.

FOR MORE INFORMATION:

Call Bayer Veterinary Services at (800) 422-9874 or visit www.Baytril100.com.

Baytril 100